SCHEMBL4029004

SCHEMBL4029004

O=C(c1ccc2c3c(ccc2c1)OCCC3)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
CTNNB1 P35222 5/20 0.36
WNT3A P56704 5/20 0.36
VNN1 O95497 2/20 0.35
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GRM1 Q13255 2/20 0.32
PIR O00625 1/20 0.31
HSF1 Q00613 1/20 0.31
KMT2A Q03164 2/20 0.31
ENPP2 Q13822 1/20 0.31
TP53 P04637 2/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4023986 0.94 VNN1 (0.36) NPC1RAB9ACTNNB1WNT3AVNN1
SCHEMBL4033508 0.78
SCHEMBL1414934 0.76 CYP17A1 (0.41) ENPP2
SCHEMBL4031880 0.76 CTNNB1 (0.34) RAB9ACTNNB1WNT3AMAPTKMT2A
SCHEMBL1414929 0.76 SIRT2 (0.36) NPC1RAB9AMAPTKMT2AHPGD
SCHEMBL4030987 0.75 MEN1 (0.51) NPC1RAB9AMAPTKMT2AENPP2
SCHEMBL4034041 0.74 NPC1 (0.36) NPC1RAB9ACTNNB1WNT3AMAPT
SCHEMBL313125 0.72 ACSS2 (0.43)
SCHEMBL4024355 0.72 SIRT2 (0.41) NPC1RAB9AMAPTSMN1; SMN2HTT
SCHEMBL5678341 0.72 KDM4E (0.46) KMT2AHPGDKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed
EP-1222174-A1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE Takeda Chemical Industries, Ltd. (JP) 2002-07-17 EP disclosed
WO-2001030762-A1 IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-03 WO disclosed